Supporting emergency departments workers well-being: a systematic review of the literature on interventions
Abstract
Emergency departments (EDs) are high-pressure environments where healthcare workers face ongoing acute and chronic stressors, increasing the risk of burnout, anxiety, and depression. These challenges affect staff well-being, job satisfaction, and patient care. Although various interventions have been developed to improve well-being, their effectiveness remains insufficiently understood. This systematic review aims to examine interventions targeting the well-being of ED healthcare workers, focusing on individual, group, and organizational-level strategies. Following the PRISMA guidelines, a comprehensive search was conducted across four databases (PubMed, PsycINFO, Scopus, Web of Science) to identify peer-reviewed studies published between 2021 and 2024. A total of 26 articles met inclusion criteria, each evaluating well-being interventions for ED staff. Studies were categorized by intervention type—individual, group, organizational, or multilevel—and outcomes assessed. Most interventions targeted the individual level (n = 21), including mindfulness training, resilience programs, and educational approaches. Fewer studies addressed group (n = 1), organizational (n = 2), or multilevel (n = 2) interventions. Eighteen studies reported improvements in at least one well-being outcome, most commonly reductions in stress and burnout. However, only six included long-term follow-up. Overall, interventions in ED settings primarily focus on individual-level strategies and demonstrate…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 21 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.